Curis, Inc. (CRIS): Price and Financial Metrics

CRIS POWR Grades

• Value is the dimension where CRIS ranks best; there it ranks ahead of 64.02% of US stocks.
• The strongest trend for CRIS is in Stability, which has been heading down over the past 179 days.
• CRIS's current lowest rank is in the Momentum metric (where it is better than 4.64% of US stocks).

CRIS Stock Summary

• With a price/sales ratio of 21.43, Curis Inc has a higher such ratio than 93.37% of stocks in our set.
• With a year-over-year growth in debt of -34.22%, Curis Inc's debt growth rate surpasses only 11.91% of about US stocks.
• In terms of volatility of its share price, CRIS is more volatile than 91.07% of stocks we're observing.
• Stocks that are quantitatively similar to CRIS, based on their financial statements, market capitalization, and price volatility, are VYGR, AGLE, FUSN, MCRB, and CHRS.
• Visit CRIS's SEC page to see the company's official filings. To visit the company's web site, go to www.curis.com.

CRIS Valuation Summary

• In comparison to the median Healthcare stock, CRIS's price/sales ratio is 597.8% higher, now standing at 79.2.
• CRIS's price/sales ratio has moved down 161 over the prior 243 months.
• CRIS's EV/EBIT ratio has moved down 21.2 over the prior 243 months.

Below are key valuation metrics over time for CRIS.

CRIS Growth Metrics

The year over year price growth rate now stands at 1757.31%.
• Its 2 year net income to common stockholders growth rate is now at 33.85%.
• The 2 year cash and equivalents growth rate now stands at -45.42%.

CRIS's revenue has moved up $922,000 over the prior 34 months.

The table below shows CRIS's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-12-31	10.649	-37.619	-45.436
2021-09-30	10.538	-35.163	-39.333
2021-06-30	10.241	-31.43	-34.256
2021-03-31	10.315	-29.902	-30.126
2020-12-31	10.835	-25.739	-29.908
2020-09-30	11.098	-25.623	-30.999

CRIS's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• CRIS has a Quality Grade of C, ranking ahead of 36.2% of graded US stocks.
• CRIS's asset turnover comes in at 0.066 -- ranking 302nd of 682 Pharmaceutical Products stocks.
• YMTX, VTRS, and KDNY are the stocks whose asset turnover ratios are most correlated with CRIS.

The table below shows CRIS's key quality metrics over time.